⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

RPRX

Royalty Pharma plc

Healthcare · Biotechnology

63.86USD

+0.1100 (+0.17%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on RPRX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 63.86
P/E45.3
Dvd Ind Yld1.5%
P/B3.77
P/S14.6
Curr EV/T12M EBITDA26.1
Mkt Cap (USD)36.9B
Curr EV (USD)39.5B
2)

Per Share Data

EPS T12M1.76
DPS0.94
Bk Val Per Sh15.33
Rev/Sh4.55
Cash/Sh1.88
Curr Shares Out445.3M
FCF/Sh-2.15
3)

Cash Flow Analysis

P/CF12.4
Curr P/FCF-30.9
CF/NI3.7
Dvd P/O48.4%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales117.4%
Eff Interest Rate4.3%
4)

Growth Potential

Dil EPS 1Y Gr-6.8%
Cap 1Y Gr4.0%
BPS 1Y Gr-1.1%
R&D To Sales9.4%
Retention Rate51.6%
Rev 1Y Gr5.1%
FCF 1Y Gr—
Assets 1Y Gr7.7%
5)

Profitability

EBITDA1.5B
EBIT1.5B
Operating Margin59.6%
Pretax Margin53.2%
Net Margin32.1%
ROA4.3%
ROE8.5%
ROC8.1%
Asset Turnover0.13
6)

Structure

Current Ratio2.80
Quick Ratio2.79
Debt/Assets45.2%
Debt/Com Eq91.6%
Net Debt/EBITDA5.37
Tot Debt/Capital47.8%
Gross Margin95.8%
EBIT/Int Exp4.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.